Latest updates for Arwr

Fresh curated links around ARWR are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Arrowhead Pharmaceuticals: The Fast-Follower Math Behind A $215 Million Voucher
  • Arrowhead Pharmaceuticals, Inc. (ARWR) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript
  • Arrowhead

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /3 weeks ago

Arrowhead Pharmaceuticals: The Fast-Follower Math Behind A $215 Million Voucher

Read source
seekingalpha.com /1 month ago

Arrowhead Pharmaceuticals, Inc. (ARWR) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference Transcript

Read source
cafepharma.com /14 hours ago

Arrowhead

Arrowhead Anonymous (not verified) Fri, 10/23/2026 - 13:17 field_thread_url https://cafepharma.com/boards/threads/arrowhead.708698/ boar...

Read source
fool.com /1 month ago

Arrowhead Pharmaceuticals Director Sells 11,600 Shares for $1 Million

Perry's liquidity event comes as the Arrowhead stock price surged.

Read source
seekingalpha.com /1 day ago

ARMOUR Residential REIT, Inc. (ARR) Q3 2026 Earnings Call Transcript

Read source
seekingalpha.com /4 weeks ago

Arjo AB (publ) (ARRJF) Analyst/Investor Day - Slideshow

Read source
seekingalpha.com /1 week ago

Acrux Limited (ARUXF) Shareholder/Analyst Call Transcript

Read source
wishingwealthblog.com /2 weeks ago

Day 11 of $QQQ short term up-trend, its Weekly 10.4 Stochastic= 86, a sign of a strong up-trend, see GMI table; ARW had...

IndicatorsGMI: 3/6GMI-2: 6/9T2108: 21%I think this market is strengthening into 3rd quarter earnings. Many down markets have bottomed in October. Remember to “come back at Hallowee...

Read source
qchron.com /3 weeks ago

AARD Deadline: AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit

NEW YORK, Oct. 2, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Aardvark Therapeutics, Inc. (NASDAQ: AARD): (i) common stock pu...

Read source
seekingalpha.com /1 month ago

AmRest Holdings SE (ARHOF) Q2 2026 Earnings Call Transcript

Read source
qchron.com /3 weeks ago

ARS Pharmaceuticals Deadline: SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit

NEW YORK, Oct. 2, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) between March...

Read source
fool.com /3 weeks ago

AAR (AIR) Q1 2027 Earnings Call Transcript

MRO Holdings acquisition positions AAR for $4.3B revenue scale and 19-20% margins.

Read source
qchron.com /1 month ago

SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit

NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) between Marc...

Read source
cafepharma.com /1 month ago

AWM 2026 Direction

AWM 2026 Direction Anonymous (not verified) Wed, 09/23/2026 - 21:57 field_thread_url https://cafepharma.com/boards/threads/awm-2026-direction.712673/...

Read source
seekingalpha.com /1 month ago

Arrow Exploration Corp. (AXL:CA) Shareholder/Analyst Call Prepared Remarks Transcript

Read source
seekingalpha.com /2 weeks ago

Ironwood Pharmaceuticals: The Stock Is A Call On The Second Apraglutide Trial - Buy

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Arwr

seekingalpha.com

Recent coverage from public sources
Public source

cafepharma.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

fool.com

Recent coverage from public sources
Public source

qchron.com

Recent coverage from public sources
Public source

wishingwealthblog.com

Recent coverage from public sources
Public source